Dr. Reddy’s Laboratories has announced the appointment of a new chief operating officer. This comes following the news that after a 15-year career with the company, Mr. Abhijit Mukherjee, current chief operating officer, is retiring.

Mr. Mukherjee will be succeeded by Mr. Erez Israeli, former president & chief executive officer of Enzymotec. Mr. Israeli will join Dr. Reddy’s as both chief operating officer, and global head of Generics & PSAI. 

Israeli has 25 years of industry experience, and has held leadership positions that have contributed significantly to the performance of companies he worked for. Prior to Enzymotec, he completed 23 years with Teva Pharmaceuticals Limited, where he held several positions of responsibility including vice president Marketing & Sales for North America,  and president & chief executive officer, Growth Markets. He will report to Dr. Reddy’s co-chairman & chief executive officer, G.V. Prasad. 

G.V. Prasad said, “I would like to thank Abhijit for his valuable contribution to our company’s growth journey over the past fifteen years. I extend a warm welcome to Erez Israeli. Erez is an accomplished leader with a proven track record of achievement. His knowledge and experience from leading pharmaceutical businesses of scale will be valuable for our future growth.”